- Home
- OLMA vs VEL Comparison
OLMA vs VEL Comparison
Compare OLMA & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OLMA | VEL |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 949.3M | 765.5M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OLMA | VEL |
|---|---|---|
| Price | $9.84 | $16.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $44.89 | $22.00 |
| AVG Volume (30 Days) | ★ 817.3K | 113.0K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.00 | ★ 43.98 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.01 |
| Revenue Next Year | N/A | $19.02 |
| P/E Ratio | ★ N/A | $13.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.65 | $16.06 |
| 52 Week High | $36.26 | $21.40 |
Technical Indicators
Market Signals| Indicator | OLMA | VEL |
|---|---|---|
| Relative Strength Index (RSI) | 39.97 | 24.66 |
| Support Level | $9.06 | N/A |
| Resistance Level | $11.27 | $19.03 |
| Average True Range (ATR) | 0.54 | 0.54 |
| MACD | -0.06 | -0.25 |
| Stochastic Oscillator | 25.00 | 29.62 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.